UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 285

Sortiert nach

Assessing racial and ethnic disparities using a COVID-19 outcomes continuum for New York State

Annals of epidemiology, 2020-08, Vol.48, p.9-14

2020

Volltextzugriff (PDF)

Costs and consequences of the US Centers for Disease Control and prevention's recommendations for opt-out HIV testing

PLoS medicine, 2007-06, Vol.4 (6), p.1011-1018

2007

Volltextzugriff (PDF)

U.S. HIV Incidence and Transmission Goals, 2020 and 2025

American journal of preventive medicine, 2017-09, Vol.53 (3), p.275-281

2017

Volltextzugriff (PDF)

Xylazine — Medical and Public Health Imperatives

The New England journal of medicine, 2023-06, Vol.388 (24), p.2209-2212

2023

Volltextzugriff (PDF)

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021

MMWR. Morbidity and mortality weekly report, 2021-08, Vol.70 (34), p.1150-1155

2021

Volltextzugriff (PDF)

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

JAMA : the journal of the American Medical Association, 2020-06, Vol.323 (24), p.2493

2020

Volltextzugriff (PDF)

HIV transmission rates from persons living with HIV who are aware and unaware of their infection

AIDS (London), 2012-04, Vol.26 (7), p.893-896

2012

Volltextzugriff (PDF)

Demographic Trends in New HIV Diagnoses in the U.S., 2009−2013

American journal of preventive medicine, 2016-12, Vol.51 (6), p.1044-1050

2016

Volltextzugriff (PDF)

Factors affecting engagement between academic faculty and decision-makers: learnings and priorities for a school of public health

Health research policy and systems, 2018-07, Vol.16 (1), p.65-65, Article 65

2018

Volltextzugriff (PDF)

Exploring the evolution of engagement between academic public health researchers and decision-makers: from initiation to dissolution

Health research policy and systems, 2020-02, Vol.18 (1), p.15-15, Article 15

2020

Volltextzugriff (PDF)

Transforming Management of Opioid Use Disorder with Universal Treatment

The New England journal of medicine, 2022-10, Vol.387 (15), p.1341-1344

2022

Volltextzugriff (PDF)

Medical and Public Health Imperatives of Xylazine. Reply

The New England journal of medicine, 2023-08, Vol.389 (8), p.771-772

2023

Volltextzugriff (PDF)

A 2023 Agenda for Substance Use Prevention and Treatment in the US

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (9), p.707

2023

Volltextzugriff (PDF)

Widespread and Frequent Testing is Essential to Controlling Coronavirus Disease 2019 (COVID-19) in the United States

Clinical infectious diseases, 2021-11, Vol.73 (9), p.e2918-e2920

2021

Volltextzugriff (PDF)

States' Methods for Capturing and Reporting Local Responses to Suspected Nonfatal Drug Overdoses

JAMA : the journal of the American Medical Association, 2023-03, Vol.329 (9), p.761

2023

Volltextzugriff (PDF)

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York

Annals of epidemiology, 2020-08, Vol.48, p.23-29.e4

2020

Volltextzugriff (PDF)

Medical costs and quality-adjusted life years associated with smoking: a systematic review

BMC public health, 2016-07, Vol.16 (1), p.646-646, Article 646

2016

Volltextzugriff (PDF)

Effects of States’ Methods for Estimating Nonfatal Overdose, United States, 2021

Public health reports (1974), 2024-07, p.333549241263526

2024

Volltextzugriff (PDF)

Assessing the Population-Level Prevention Effect of Emergency Department–Based HIV Testing in the United States: A Research Framework and Commentary

Annals of emergency medicine, 2011-07, Vol.58 (1), p.S164-S167

Holtgrave, David R., PhD

2011

Volltextzugriff (PDF)

Determining the Most Appropriate Use of Available Regimens for HIV Preexposure Prophylaxis

Annals of internal medicine, 2022-04, Vol.175 (4), p.600

2022

Volltextzugriff (PDF)

Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use

American journal of preventive medicine, 2021-03, Vol.60 (3), p.335-342

2021

Volltextzugriff (PDF)

Trends in diagnoses of HIV infection in the United States, 2002-2011

JAMA : the journal of the American Medical Association, 2014-07, Vol.312 (4), p.432

2014

Volltextzugriff (PDF)

Advocacy, activism, and lobbying: How variations in interpretation affects ability for academia to engage with public policy

PLOS global public health, 2022, Vol.2 (3), p.e0000034-e0000034

2022

Volltextzugriff (PDF)

Cost–Utility Analysis of the National truth® Campaign to Prevent Youth Smoking

American journal of preventive medicine, 2009-05, Vol.36 (5), p.385-388

2009

Volltextzugriff (PDF)

Data-Driven Goals for Curbing the U.S. HIV Epidemic by 2030

AIDS and behavior, 2019-03, Vol.23 (3), p.557-563

2019

Volltextzugriff (PDF)

1 – 25 von 285

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(261)
Mit Volltextzugriff
(200)

Publikationsform

Sprache

Englisch
(285)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Humans
(205)
Science & Technology
(200)
Life Sciences & Biomedicine
(197)
Hiv
(137)
Human Immunodeficiency Virus
(128)
Public, Environmental & Occupational Health
(123)
Hiv Infections - Prevention & Control
(109)
Public Health
(99)
Aids/hiv
(96)
Infectious Diseases
(93)
Acquired Immune Deficiency Syndrome
(89)
Aids
(85)
United States
(83)
Male
(72)
Prevention
(72)
Social Sciences
(72)
Female
(65)
Cost-Benefit Analysis
(57)
United States - Epidemiology
(54)
Biological And Medical Sciences
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Assessing racial and ethnic disparities using a COVID-19 outcomes continuum for New York State

Costs and consequences of the US Centers for Disease Control and prevention's recommendations for opt-out HIV testing

U.S. HIV Incidence and Transmission Goals, 2020 and 2025

Xylazine — Medical and Public Health Imperatives

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State

HIV transmission rates from persons living with HIV who are aware and unaware of their infection

Demographic Trends in New HIV Diagnoses in the U.S., 2009−2013

Factors affecting engagement between academic faculty and decision-makers: learnings and priorities for a school of public health

Exploring the evolution of engagement between academic public health researchers and decision-makers: from initiation to dissolution

Transforming Management of Opioid Use Disorder with Universal Treatment

Medical and Public Health Imperatives of Xylazine. Reply

A 2023 Agenda for Substance Use Prevention and Treatment in the US

Widespread and Frequent Testing is Essential to Controlling Coronavirus Disease 2019 (COVID-19) in the United States

States' Methods for Capturing and Reporting Local Responses to Suspected Nonfatal Drug Overdoses

Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York

Medical costs and quality-adjusted life years associated with smoking: a systematic review

Effects of States’ Methods for Estimating Nonfatal Overdose, United States, 2021

Assessing the Population-Level Prevention Effect of Emergency Department–Based HIV Testing in the United States: A Research Framework and Commentary

Determining the Most Appropriate Use of Available Regimens for HIV Preexposure Prophylaxis

Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use

Trends in diagnoses of HIV infection in the United States, 2002-2011

Advocacy, activism, and lobbying: How variations in interpretation affects ability for academia to engage with public policy

Cost–Utility Analysis of the National truth® Campaign to Prevent Youth Smoking

Data-Driven Goals for Curbing the U.S. HIV Epidemic by 2030

Suchergebnisse filtern